---
title: "Vivos Therapeutics (VVOS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/VVOS.US/norm.md"
symbol: "VVOS.US"
name: "Vivos Therapeutics"
parent: "https://longbridge.com/en/quote/VVOS.US.md"
datetime: "2026-05-20T14:41:35.163Z"
locales:
  - [en](https://longbridge.com/en/quote/VVOS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/VVOS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/VVOS.US/norm.md)
---

# Vivos Therapeutics (VVOS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.5549 | -0.4925 | -0.5517 | -0.4495 | -0.3909 |
| ROE | -5292.90% | -607.17% | -446.10% | -250.08% | -144.80% |
| Revenue | 3.82M | 6.78M | 3.82M | 3.02M | 3.70M |
| Net income | -6.89M | -5.40M | -5.01M | -3.86M | -2.83M |
| Operating income | -6.38M | -4.73M | -4.87M | -3.92M | -2.81M |
| Gross margin | 78.14% | 58.04% | 55.24% | 50.03% | 56.71% |
| Net margin | -180.28% | -79.61% | -131.23% | -128.12% | -76.45% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 25.15M | 25.64M | 26.03M | 11.28M | 15.28M |
| Leverage | -16.23 | 10.13 | 5.68 | 2.56 | 1.92 |
| BVPS | -0.1604 | 0.3063 | 0.6257 | 0.7483 | 1.35 |
| Turnover | 0.8627 | 0.8449 | 0.6874 | 1.27 | 1.16 |
| Cash & STI | 2.03M | 3.09M | 4.40M | 2.34M | 6.26M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 7.92M | 9.03M | 8.37M | 4.26M | 4.34M |
| Net debt | 11.47M | 9.41M | 7.18M | -943000.00 | -4.75M |

## Cash Flow Statement (USD)

| Indicator | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -3.81M | -4.16M | -3.49M | -3.80M | -2.94M |
| Investing CF | -1.58M | 83000.00 | -5.91M | -122000.00 | -165000.00 |
| Financing CF | 4.33M | 2.76M | 11.46M | - | 3.05M |
| Free CF | -1.96M | -2.01M | -2.94M | -2.40M | -1.93M |
| OCF coverage | -247.21% | 6304.55% | -453.18% | -3111.48% | -1781.82% |
| Repaid & issued | 1.45M | -417000.00 | 9.64M | - | - |
| CapEx | -1.53M | 83000.00 | -771000.00 | -122000.00 | -165000.00 |